Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis
Public ClinicalTrials.gov record NCT01975610. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, 4-Week Double-Blind, Proof-of-Concept Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
CC-292 is an oral agent that is under clinical development for the treatment of rheumatoid arthritis an autoimmune inflammatory disorder. This study will test the clinical effectiveness and safety of an orally (PO) administered dose of CC-292 compared to placebo in US female patients currently on background Methotrexate (MTX) with active Rheumatoid Arthritis (RA
Study identification
- NCT ID
- NCT01975610
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 47 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2013 (Type not available)
- Primary completion
- Jan 2016 (Actual)
- Completion
- Feb 2016 (Actual)
- Last update posted
- Jul 31, 2017
2013 – 2016
United States locations
- U.S. sites
- 27
- U.S. states
- 20
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Achieve Clinical Research LLC | Birmingham | Alabama | 35216 | — |
| Arizona Arthritis and Rheumatology Research, PLLC | Phoenix | Arizona | 85023 | — |
| Generations Medical Research | Hot Springs | Arkansas | 71913 | — |
| UCLA | Los Angeles | California | 90095 | — |
| Joao Nascimento, MD | Bridgeport | Connecticut | 6606 | — |
| Southeastern Integrated Medical | Gainesville | Florida | 32607 | — |
| Family Arthritis Center | Jupiter | Florida | 33458 | — |
| Ocala Rheumatology Research Center | Ocala | Florida | 34474 | — |
| Integral Rheumatology and Immunology specialists | Plantation | Florida | 33324 | — |
| Columbia Medical Practice | Columbia | Maryland | 21045 | — |
| Clinical Pharmacology Study Group | Worcester | Massachusetts | 01610 | — |
| Borgess Research Institute | Kalamazoo | Michigan | 49048 | — |
| Arthritis and Osteoporosis Associates | Freehold | New Jersey | 07728 | — |
| Albuquerque Clinic | Albuquerque | New Mexico | 87102 | — |
| NYU Langone Medical Center | New York | New York | 10016 | — |
| DJL Clinical Research | Charlotte | North Carolina | 28210 | — |
| Lynn Health Science Instiute | Oklahoma City | Oklahoma | 73112 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Med Univ of South Carolina | Charleston | South Carolina | 29425 | — |
| PMG Research of Charlotte LLC | Rock Hill | South Carolina | 29732 | — |
| West Tennessee Research Institute | Jackson | Tennessee | 38305 | — |
| Ramesh C Gupta MD | Memphis | Tennessee | 38119 | — |
| Austin Regional Clinic | Austin | Texas | 78731 | — |
| DM Clinical Research | Houston | Texas | 77070 | — |
| Mountain State Clinical Research | Clarksburg | West Virginia | 26301 | — |
| Froedtert Hospital BMT Medical College of Wisconsin | Milwaukee | Wisconsin | 53226-3522 | — |
| Gundersen Clinic Ltd | Onalaska | Wisconsin | 54650 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01975610, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2017 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01975610 live on ClinicalTrials.gov.